Abstract
The overwhelming majority of differentiated thyroid cancers are curable, and this optimistic outlook applies particularly to stage I, II, and most stage III tumors. Stage IV tumors are typically and clearly in a different category, as the prognosis is significantly worse once distant metastases are present. In the author’s view, a worse prognosis is not a justification for therapeutic nihilism but instead demands more aggressive therapy, with the hopeful expectation of improving outcome and prognosis. Not infrequently, some stage I and II patients have local disease that is resistant to ablation by conventional surgery and radioiodine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bennedbaek FN, Hegedus L. Treatment of rrecurrent thyroid cysts with ethanol: a randomized double-blind controlled trial. J Clin Endocrinol Metab 2003; 88:5773–5777.
Guglielmi R, Pacella CM, Bianchini A, et al. Percutaneous ethanol injection treatment in benign thyroid lesions: Role and efficacy. Thyroid 2004; 14:125–131.
Gangi A, Kastler B, Klinkert A, Dietemann JL. Injection of alcohol into bone metastases under CT guidance. J Comput Assist Tomogr 1994; 18:932–935.
Lewis BD, Hay ID, Charboneau JW, et al. Percutaneous ethanol injuection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. Am J Roentgenol 2002; 178:699–704.
Hay I, Charboneau W, Lewis B, et al. Successful ultrasound-guided percutaneous ethanol ablation of neck nodal metastases in 20 patients with postoperative TNM Stage I papillary thyroid carcinoma resistant to conventional therapy. Los Angeles, CA: 74th Meeting, American Thyroid Association, 2002; Abstract 176.
Nakada K, Kasai K, Watanabe Y, et al. Treatment of radioiodinenegative bone metastasis from papillary thyroid carcinoma with percutaneous ethanol injection therapy. Ann Nucl Med 1996; 10:441–444.
Schlumberger M, Challeton C, De Vathaire F, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 1996; 37:598–605.
Bernier M-O, Leenhardt L, Hoang C, et al. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinoma. J Clin Endocrinol Metab 2001; 86:1568–1573.
Camille RR, Leger FA, Merland JJ, et al. Recent advances in the treatment of bone metastases from cancer of the thyroid. Chirurgie 1980; 106:32–36.
Smit JW, Vielvoye GJ, Goslings BM. Embolization for vertebral metastases of follicular thyroid carcinoma. J Clin Endocrinol Metab 2000; 85:989–994.
Vitale G, Fonderico F, Martignetti A, et al. Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer. Br J Cancer 2001; 84:1586–1590.
Rosen HN, Moses AC, Garber J, et al. Randomized trial of pamidronate in patients with thyroid cancer: Bone density is not reduced by suppressive doses of thyroxine, but is increased by cyclic intravenous pamidronate. J Clin Endocrinol Metab 1998; 83:2324–2330.
Rosen LS, Gordon D, Tchekmedyian S, et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: A phase III, double-blind, randomized trial-The Zoledronic acid lung cancer and other solid tumors study group. J Clin Oncol 2003; 21:3150–3157.
Rosen LS, Gordon D, Tchekmedyian NS, et al. Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with non-small cell lung carcinoma and other solid tumors. Cancer 2004; 100:2613–2621.
Eustatia-Rutten CF, Romijn JA, Guijt MJ, et al. Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma. J Clin Endocrinol Metab 2003; 88:3184–3189.
Van Tol KM, Hew JM, Jager PL, et al. Embolization in combination with radioiodine therapy for bone metastases from differentiated thyroid carcinoma. Clin Endocrinol 2000; 52:653–659.
Elshafie O, Hussein S, Jeans WD, Woodhouse NJ. Massive rise in thyroglobulin with adult respiratory distress syndrome after embolisation of thyroid cancer metastasis. Br J Radiol 2000; 73:547–549.
Halpin RJ, Bendok BR, Liu JC. Minimally invasive treatments for spinal metastases: vertebroplasty, kyphoplasty, and radiofrequency ablation. J Support Oncol 2004; 2:339–355.
Peh WC, Gilula LA. Percutaneous vertebroplasty: Indications, contraindications, and technique. Br J Radiol 2003; 76:69–75.
Ahmad Z, Abbasi F, Mitsunaga M, Portner B. Pain reduction and functional improvement after kyphoplasty: a retrospective study of 50 patients. Arch Phy Med Rhab 2003; 84:A21.
Ledlie JT, Fenfro M. Balloon kyphoplasty: one-year outcomes in vertebral body height restoration, chronic pain, and activity levels. J Neurosurg 2003; 98:36–42.
McGahan JP, Dodd GD. Radiofrequency ablation o the liver: current status. AJR Am J Roentgenol 2001; 176:3–16.
Dupuy DE. Minimally invasive therapies in the treatment of bone malignancies. Crit Rev 1998; 75:161–171.
Goetz MP, Callstrom MR, Charboneau JW, et al. Percutaneous imageguided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 2004; 22:300–306.
Schaefer O, Lohrmann C, Ghanem N, Langer M. CT-guided radiofrequency heat ablation of malignant lung tumors. Med Sci Monit 2003; 9:127–131.
Dupuy DE, Zagoria RJ, Akerley W, et al. Percutaneous radiofrequency ablation of malignancies in the lung. Am J Roentgenol 2000; 174:57–59.
Schaefer O, Lohrmann C, Markmiller M, et al. Technical innovation: combined treatment of a spinal metastasis with radiofrequency heat ablation and vertebroplasty. Am J Roentgenol 2003; 180:1075–1077.
Halpin RJ, Bendok BB, Sato KT, et al. Combination treatment of vertebral metastases using image-guided percutaneous radiofrequency ablation and vertebroplasty: a case report. Surg Neurol 2005; 63:469–474.
Dupuy DE, Monchik JM, Decrea C, Pisharodi L. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery 2001; 130:971–977.
Callstrom MR, Charboneau JW, Goetz MP, et al. Painful metastases involving bone: Feasibility of percutaneous CT-and US-guided radiofrequency ablation. Radiology 2002; 224:87–97.
Pacella CM, Bizzarri G, Ferrari FS, et al. Interstitial photocoagulation with laser in the treament of liver metastases. Radiol Med 1996; 92:438–447.
Pacella CM, Bizzarri G, Magnolfi F, et al. Laser thermal ablation in the treatment of small hepatocellular carcinoma: Results in 74 patients. Radiology 2001; 221:712–720.
Guglielmi R, Pacella CM, Dottorini MF, et al. Severe thyrotoxicosis due to hyperfunctioning liver metastases from follicular carcinoma treatment with 131-I and interstitial laser ablation. Thyroid 1999; 9:173–177.
Pacella CM, Bizzarri G, Guglielmi R., et al. Thyroid tissue: USguided percutaneous interstital laswer ablation—a feasibility study. Radiology 2000; 217:673–677.
Pacella CM, Bizzarri G, Spiezia S, et al. Thyroid tissue: US-guided percutaneous laser thermal ablation. Radiology 2004; 232:272–280.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Wartofsky, L. (2006). Adjunctive Local Approaches to Metastatic Thyroid Cancer. In: Wartofsky, L., Van Nostrand, D. (eds) Thyroid Cancer. Humana Press. https://doi.org/10.1007/978-1-59259-995-0_57
Download citation
DOI: https://doi.org/10.1007/978-1-59259-995-0_57
Publisher Name: Humana Press
Print ISBN: 978-1-58829-462-3
Online ISBN: 978-1-59259-995-0
eBook Packages: MedicineMedicine (R0)